Your session is about to expire
What is Ddavp
DesmopressinThe Generic name of this drug
Treatment SummaryDesmopressin (dDAVP) is a synthetic hormone used to treat conditions that involve excessive urination, such as nocturia, diabetes insipidus, and primary nocturnal enuresis. It also helps treat mild classical hemophilia and von Willebrand's disease for minor surgeries. Desmopressin is an improved version of the naturally occurring hormone vasopressin, and it was approved by the FDA in 2018. It is available in a variety of forms, including intranasal solution, intravenous solution, oral tablets, and sublingual tablets.
Ddavpis the brand name
Ddavp Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Ddavp
Desmopressin
1978
101
Effectiveness
How Ddavp Affects PatientsDesmopressin is a drug that helps the body retain water by mimicking the action of a natural hormone, anti-diuretic hormone (ADH). It is more effective than ADH at increasing the levels of factor VIII in patients with hemophilia and von Willebrand's disease. Desmopressin does not increase blood pressure like some other drugs, and is much less effective when taken as a nasal spray than as an injection.
How Ddavp works in the bodyWhen desmopressin binds to V2 receptors in the kidneys, it causes cells in the distal tubule and collecting ducts to insert water channels, called aquaporins, into the membrane. This increases the permeability of the membrane to water.
When to interrupt dosage
The measure of Ddavp is contingent upon the diagnosed malady, including Minor Surgical Procedures, Pituitary Gland and Surgery, Hemophilia A. The portion of dosage is contingent upon the approach of delivery featured in the table beneath.Condition
Dosage
Administration
Pituitary Surgery
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
von Willebrand Disease
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Primary Nocturnal Enuresis
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Polyuria
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Hemophilia As
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Uremia
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Hemophilia
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Hemorrhage
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Nocturia
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Polyuria
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Polydipsia
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
von Willebrand Disease
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Surgery, Hemophilia A
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
pituitary trauma
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Hemorrhage
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Central Diabetes Insipidus
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Minor Surgical Procedures
0.1 mg, 0.2 mg, , 0.1 mg/mL, 0.004 mg/mL, 0.0001 mg/mL, 0.01 mg, 0.06 mg, 0.12 mg, 0.24 mg, 0.025 mg, 0.05 mg, 1.5 mg/mL, 0.00083 mg, 0.00166 mg, 0.0277 mg, 0.0553 mg, 0.015 mg/mL, 0.01 mg/pump actuation, 0.15 mg/pump actuation
, Oral, Tablet, Tablet - Oral, Nasal, Solution, Solution - Nasal, Intravenous, Solution - Intravenous, Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intravenous; Subcutaneous, Injection, Injection - Intravenous, Spray, Spray - Nasal, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Intramuscular; Intravenous; Subcutaneous, Spray, metered, Spray, metered - Nasal, Sublingual, Tablet, orally disintegrating - Sublingual, Tablet, orally disintegrating, Aerosol, metered, Aerosol, metered - Nasal, Tablet - Sublingual, Injection - Intravenous; Subcutaneous, Solution - Intramuscular; Intravenous; Subcutaneous, Solution - Intravenous; Subcutaneous
Warnings
Ddavp ContraindicationsCondition
Risk Level
Notes
history of hyponatremia
Do Not Combine
Renal Insufficiency
Do Not Combine
Hyponatremia
Do Not Combine
Common Ddavp Drug Interactions
Drug Name
Risk Level
Description
1-benzylimidazole
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 1-benzylimidazole.
2,5-Dimethoxy-4-ethylamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylamphetamine.
2,5-Dimethoxy-4-ethylthioamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
4-Bromo-2,5-dimethoxyamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Bromo-2,5-dimethoxyamphetamine.
4-Methoxyamphetamine
Minor
The risk or severity of hypertension can be increased when Desmopressin is combined with 4-Methoxyamphetamine.
Ddavp Toxicity & Overdose RiskTaking too much desmopressin can cause a low level of sodium, or hyponatremia. Symptoms of this include seizures, disorientation, confusion, drowsiness, or a continuing headache, as well as an irregular heartbeat and swelling. If you think you have taken too much desmopressin, lower the dose or stop taking it. Have your sodium levels checked by a doctor, and start any necessary treatment.
Ddavp Novel Uses: Which Conditions Have a Clinical Trial Featuring Ddavp?
There are presently 30 active studies assessing the potential of Ddavp to mitigate Polyuria, Hemophilia A and Hemophilia.Condition
Clinical Trials
Trial Phases
Surgery, Hemophilia A
0 Actively Recruiting
Polyuria
0 Actively Recruiting
Polydipsia
0 Actively Recruiting
Uremia
0 Actively Recruiting
pituitary trauma
0 Actively Recruiting
Polyuria
0 Actively Recruiting
Nocturia
6 Actively Recruiting
Phase 4, Not Applicable
Hemorrhage
13 Actively Recruiting
Phase 4, Phase 3, Not Applicable, Phase 1, Phase 2
Hemophilia
4 Actively Recruiting
Phase 3
von Willebrand Disease
2 Actively Recruiting
Phase 3
von Willebrand Disease
0 Actively Recruiting
Primary Nocturnal Enuresis
0 Actively Recruiting
Hemorrhage
0 Actively Recruiting
Minor Surgical Procedures
0 Actively Recruiting
Central Diabetes Insipidus
1 Actively Recruiting
Phase 1
Pituitary Surgery
0 Actively Recruiting
Hemophilia As
3 Actively Recruiting
Phase 3
Ddavp Reviews: What are patients saying about Ddavp?
5Patient Review
10/14/2010 We've had great success with this medication for my two kids. My son took it for about a year with no problems whatsoever, and now my daughter is taking it too. So far so good!
5Patient Review
11/30/2010 This treatment has been essential for me. I have a condition called panhypopituitarism, which means that my pituitary gland was removed. This medication helps me to control my urine flow and has literally saved my life.
5Patient Review
4/6/2014 Unfortunately, we didn't see any results from using this treatment. We followed the instructions to a tee and even doubled up when advised by our doctor, but saw no improvement. This was very frustrating and a waste of money.
5Patient Review
9/7/2010 Unfortunately, this treatment didn't work for my son at all.
5Patient Review
1/14/2013 After being diagnosed with DI, I tried the nasal spray for a year. But I wasn't convinced that it always worked, so I switched to tablets. After several changes in dosage, I feel like we've finally got it right. This medicine has honestly changed my life--I felt like I had gotten my life back. However, now I am wondering if it is changing my mood because I am feeling depressed recently.
4.7Patient Review
3/2/2016 Despite trying a number of things, my son was still wetting the bed every single night. Finally, we tried this medication and it has not worked at all. We're going to try doubling the dosage tonight and see if that makes any difference. Will update soon.
4Patient Review
9/28/2012 My daughter has been using this treatment for more than two years with great success. She uses the nasal spray, one squirt each night. However, I have noticed that she has gained weight in the last two years and I'm not sure if it's from the medicine or not. Are there any other alternatives to bedwetting than desmopressin?
3.7Patient Review
8/1/2010 My 9-year-old daughter tried this medication for bedwetting, but it didn't work at all. Additionally, she had a severe allergic reaction after just three days of use (rash).
2.3Patient Review
7/23/2015 Though it's not as effective as the nasal spray, this pill is more even in its effects and gentle on my nose. The only downside is that I have to remember to take it three times a day.
2.3Patient Review
5/14/20102Patient Review
6/20/20101.7Patient Review
4/5/2011 We just started this medication last night, and my daughter is already seeing some results. However, I'm concerned about the potential side effects of this drug, specifically with regards to mood changes or obsessive behaviors in children. Has anyone else experienced this?
Patient Q&A Section about ddavp
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is DDAVP given for?
"DDAVP is used to help stop bleeding in patients with von Willebrand's disease or mild hemophilia A by causing the release of von Willebrand's antigen from the platelets and the cells that line the blood vessels where it is stored."
Answered by AI
What is the difference between desmopressin and DDAVP?
"This medication is used to treat diabetes insipidus, bedwetting, hemophilia A, von Willebrand disease, and high blood urea levels."
Answered by AI
What is DDAVP in diabetes insipidus?
"Desmopressin is a synthetic form of vasopressin that helps decrease the amount of urine made by working on the kidneys."
Answered by AI
How does DDAVP work for bleeding?
"DDAVP works by increasing the levels of factor VIII and von Willebrand factor in the blood, which typically last for 12 to 24 hours. This effect is usually enough to control minor bleeding and to prevent bleeding during minor operations, such as dentistry."
Answered by AI